Literature DB >> 22753275

Application of model-based methods to characterize exenatide-loaded double-walled microspheres: in vivo release, pharmacokinetic/pharmacodynamic model, and in vitro and in vivo correlation.

Xingang Li1, Liang Li, Xipei Wang, Yupeng Ren, Tianyan Zhou, Wei Lu.   

Abstract

The objective of this study was to characterize exenatide double-walled microspheres (DWMS) using model-based methods. Exenatide DWMS were prepared using oil-in-oil-in-water method, and physicochemical characterization and in vitro release and degradation of DWMS were evaluated. The pharmacokinetics (PK) and pharmacodynamics (PD) were investigated after subcutaneous injection to diabetic rats. Transit compartment model was used to describe the in vivo release of exenatide from DWMS successfully. On the basis of the insulinotropic effects of exenatide and hypoglycemic effects of insulin, PK/PD model was developed and nicely described the concentration-effect relationship of exenatide. Moreover, on the basis of the transit compartment model, a simulation method was applied to predict in vivo release, and in vitro and in vivo correlation was established. In conclusion, DWMS was a promising vehicle for delivery of exenatide, and the proposed PK/PD model allowed a better understanding of the pharmacological properties of exenatide DWMS. Transit compartment model-based modeling and simulation methods provided more options for the description and prediction of the in vivo exenatide release from DWMS.
Copyright © 2012 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753275     DOI: 10.1002/jps.23236

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Tunable delayed controlled release profile from layered polymeric microparticles.

Authors:  D Dutta; C Fauer; K Hickey; M Salifu; S E Stabenfeldt
Journal:  J Mater Chem B       Date:  2017-03-13       Impact factor: 6.331

2.  Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.

Authors:  Mengshu Wang; Yong Zhang; Jiao Feng; Tiejun Gu; Qingguang Dong; Xu Yang; Yanan Sun; Yongge Wu; Yan Chen; Wei Kong
Journal:  Int J Nanomedicine       Date:  2013-03-15

Review 3.  Long-acting preparations of exenatide.

Authors:  Yunpeng Cai; Liangming Wei; Liuqing Ma; Xiwen Huang; Anqi Tao; Zhenguo Liu; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-09-05       Impact factor: 4.162

4.  Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge.

Authors:  Liming Yuan; Yiting Cao; Qian Luo; Wenyu Yang; Xiaofeng Wu; Xiaoping Yang; Di Wu; Siyuan Tan; Ge Qin; Jia Zhou; Yue Zeng; Xinghua Chen; Xiaojun Tao; Qiufang Zhang
Journal:  Nanoscale Res Lett       Date:  2018-10-10       Impact factor: 4.703

5.  Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency.

Authors:  Xiaojun Tao; Ting Tao; Yi Wen; Jiajin Yi; Lihua He; Zixuan Huang; Yu Nie; Xiaoyan Yao; Yingying Wang; Chunlian He; Xiaoping Yang
Journal:  Nanoscale Res Lett       Date:  2018-10-30       Impact factor: 4.703

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.